This NIDA P20 Pilot Proteomics Center is centered upon using cutting-edge proteomic technologies to study HIV infection, host response, and subsequent pathological effects associated with opioid use and treatment. The Center has a strong multidisciplinary character, augmented by diverse complementary technologies and a team of expert project Pis utilizing both clinical and basic research. Such diversity requires a strong administrative'and organizational structure to successfully carry out the multidisciplinary research, facilitate interactions, and to promote synergy between programmatic elements. The function of the Administrative Core is to provide an overall organizational structure and support the administrative activities of the Center, interface with NIH/NIDA staff, foster cooperation between projects and cores, encourage criticism and advice from it's scientists, promote fiscal responsibility, and provide a flexible administrative structure to assure the continued excellence of the overall center and its ability to address the specific aims. This core organization includes the overall administrative structure as well as role for the Director, Administrator, External Advisory Board, and Internal Steering Committee. Specifically, the administrative Core aims to 1. Provide an organizational and programmatic structure to promote scientific interactions, 2. Provide oversight, planning, priority setting, and decision-making processes, and 3. Ensure that the Center meets all criteria for a NIDA P20 Center.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA026134-03
Application #
8077975
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2012-05-31
Support Year
3
Fiscal Year
2010
Total Cost
$120,223
Indirect Cost
Name
Battelle Pacific Northwest Laboratories
Department
Type
DUNS #
032987476
City
Richland
State
WA
Country
United States
Zip Code
99352
Premeaux, Thomas A; D'Antoni, Michelle L; Abdel-Mohsen, Mohamed et al. (2018) Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. J Neurovirol :
Price, Richard W; Spudich, Serena S; Peterson, Julia et al. (2014) Evolving character of chronic central nervous system HIV infection. Semin Neurol 34:7-13
Peterson, Julia; Gisslen, Magnus; Zetterberg, Henrik et al. (2014) Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One 9:e116081
Dominy, Stephen S; Brown, Joseph N; Ryder, Mark I et al. (2014) Proteomic analysis of saliva in HIV-positive heroin addicts reveals proteins correlated with cognition. PLoS One 9:e89366
Grund, Birgit; Wright, Edwina J; Brew, Bruce J et al. (2013) Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. J Neurovirol 19:383-92
Price, Richard W; Peterson, Julia; Fuchs, Dietmar et al. (2013) Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. J Neuroimmune Pharmacol 8:1147-58
Piehowski, Paul D; Petyuk, Vladislav A; Sandoval, John D et al. (2013) STEPS: a grid search methodology for optimized peptide identification filtering of MS/MS database search results. Proteomics 13:766-70
Brown, Joseph N; Ortiz, Gabriel M; Angel, Thomas E et al. (2012) Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels. Mol Cell Proteomics 11:605-18